Clinical evaluation of the new Pall leucocyte-depleting blood cardioplegia filter (BC1)

Abstract

It is now widely acknowledged that autologous leucocytes are inappropriately activated during cardiopulmonary bypass (CPB). Removal of these activated leucocytes has been proposed as a clinical intervention. Several papers have recently reported benefits of systemic leucocyte depletion during CPB. There is also evidence that leucocyte-depleted blood cardioplegia is advantageous in the globally ischaemic human heart transplant setting. Recently, a new leucocyte-depleting filter for blood cardioplegia has been developed (Pall, BC1). In this paper, we report on the safety and efficiency of this device in the clinical situation.

Fourteen patients undergoing routine cardiac surgery were recruited into this study. The BC1 blood cardioplegia filter was found to be an efficient leucocyte-depleting device, removing in excess of 70% (p = 0.001) of white blood cells, on average, from up to 5.3 litres of blood cardioplegia. The filter removed a small proportion of platelets (typically 11.3%), however, this was not statistically significant and no bleeding problems were encountered. Red cell removal was negligible and was not statistically significant, and no evidence of haemolysis was noted. The filter offered a very low resistance to flow with a mean pressure drop (ΔP) of 10.8 mmHg at a mean flow rate of 315 ml/min. We conclude that the Pall BC1 filter is a safe and efficient device for use with blood cardioplegia.

Get full access to this article

View all access options for this article.

References

Chenoweth DE , Cooper SW , Hugli TE , Stewart RW , Blackstone EG , Kirklin JW. Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins . N Engl J Med 1981; 304: 497-503 .

Kirklin JK , Westaby S , Blackstone EH , Kirklin JW , Chenoweth DE , Pacifico AD. Complement and the damaging effects of cardiopulmonary bypass . J Thorac Cardiovasc Surg 1983; 86: 845-857 .

Royston D. Blood cell activation . Semin Thorac Cardiovasc Surg 1990; 2: 341-357 .

Hart S , Roe JA. Leucocyte depleting filters and cardiothoracic surgery . Perfusion 1993; 8: 477-482 .

Gourlay T , Fleming J , Taylor KM. The effects of pulsatile flow on the leukocyte depleting qualities of the Pall LG6 leukocyte depleting arterial line filter: a laboratory investigation . Perfusion 1992; 7: 227-232 .

Gourlay T , Fleming J , Taylor KM. Laboratory evaluation of the Pall LG6 leukocyte depleting arterial line filter . Perfusion 1992; 7: 131-140 .

Allen S , Lloyd G , Butz H. Leucocytes and the systemic inflammatory response . J für Anasth und Intensiv 1996; 3: 38-57 .

Thurlow PG , Doolan L , Sharp R , Sullivan M , Smith B. Effect of Pall leucocyte filters LG6 and AV6 in an in vitro simulated extracorporeal circulatory system . Perfusion 1995; 10: 291-300 .

Thurlow PG , Doolan L , Sharp R , Sullivan M , Smith B , Andersen LW. Laboratory studies of the effect of Pall extracorporeal leucocyte filters LG6 and AV6 on patients undergoing coronary bypass grafts . Perfusion 1996; 11: 29-37 .

10.

Allen SM , Pagano D , Bonser RS. Preliminary clinical evaluation of the Pall Leukoguard (LG6) leucocyte depletion filter . Presented at the Scandinavian Society for Extracorporeal Technology, 42nd Annual Meeting, Pampere, Finland, 12-14 August 1993.

11.

Palanzo DA , Manley NJ , Montesano RM , Yeisley GL , Gordon D. Clinical evaluation of the Leukoguard (LG-6) arterial line filter for routine open-heart surgery . Perfusion 1993; 8: 489-496 .

12.

Palanzo DA , Manley NJ. Cost effectiveness of using a leuko-depleting arterial line filter . Presented at the American Academy of Cardiovascular Perfusion, Annual Meeting. New Orleans, LA, USA, 29 January 1994.

13.

Coleman SM , Demastrie L. Leukocyte depletion reduces postoperative oxygen requirements . Ann Thor Surg 1994; 58: 1567-1568 .

14.

Johnson D , Thomson D , Hurst T et al. Neutrophil-mediated acute lung injury after extracorporeal perfusion . J Thorac Cardiovasc Surg 1994; 107: 1193-1202 .

15.

Johnson D , Thomson D , Mycyk T et al. Depletion of neutrophils by filtration during aortocoronary bypass surgery transiently improves postoperative cardiorespiratory status . Chest 1995; 107: 1253-1259 .

16.

Hachida M , Hanayama N , Okamura T et al. The role of leucocyte depletion in reducing injury to myocardium and lung during cardiopulmonary bypass . ASAIO J 1995; 41: M291-M294 .

17.

Ogiwara M , Kyo S , Hatanaka M et al. A clinical study using the leucocyte depleting arterial line filter (LG6) for cardiopulmonary bypass . Jpn J Art Org 1996; 25: 321-324 .

18.

Al-Ebrahim K , Shaffei H. Our experience with using the Pall LG6 leucocyte depleting filter during cardiopulmonary bypass . Ann Thor Surg 1993; 56: 1216-1217 .

19.

Mihaljevic T , Tonz M , von Segesser LK et al. The influence of leucocyte filtration during cardiopulmonary bypass on post operative lung function: a clinical study . J Thorac Cardiovasc Surg 1995; 109: 1138-1145 .

20.

Van de Watering LMG , Houbiers JGA , Hermans J et al. Leucocyte depletion reduces postoperative mortality in patients undergoing cardiac surgery . Presented at the 24th Congress of the International Society for Blood Transfusion, 31 March to 5 April 1996, Abstract SY3CI-06.

21.

Gu YJ , Obster R , Gallandat Huet RCG , Eijgelaar A , van Oeveren W. Leukocyte depletion reduces the postoperative inflammatory response in patients following open heart surgery . Int Care Med 1992; 18(suppl 2): S51-S51 (Abstract 52).

22.

Gu YJ , de Vries AJ , Boonstra PW , van Oeveren W. Leucocyte depletion results in improved lung function and reduced inflammatory response after cardiac surgery . J Thorac Cardiovasc Surg 1996; 112: 494-500 .

23.

Pearl JM , Drinkwater DC , Laks H , Stein DG , Capouya ER , Bhuta S. Leukocyte-depleted reperfusion of transplanted human hearts prevents ultrastructural evidence of reperfusion injury . J Surg Res 1992; 52: 298-308 .

24.

Pearl JM , Drinkwater DC , Laks H , Capouya ER , Gates RN. Leukocyte-depleted reperfusion of transplanted human hearts: a randomized, double-blind clinical trial . J Heart Lung Transplant 1992; 11: 1082-1092 .

25.

Palatianos GM , Balentine G. Leukocyte-filtered blood cardioplegia and controlled reperfusion . European Society of Cardiovascular Surgery 43rd International Congress, Berlin, 6-9 September, 1994.

26.

Rebulla P , Dzik WH. Multicenter evaluation of methods of counting residual white cells in leukocyte depleted red blood cells . Vox Sang 1994; 66: 25-32 .

27.

Sirchia G , Rebulla P. Enumeration of low white cells. In: Sweeney J , Heaton A eds. Clinical benefits of leukodepleted blood products. New York: Springer , 1995.

28.

Pala MG , Paolini G , Paroni R et al. Myocardial protection with and without leucocyte depletion: a comparitive study on the oxidative stress . Proceedings of the Annual Meeting European Association of Cardio-Thorac Surgery, The Hague, The Netherlands, September 1994: 68-68 .

29.

Ichihara T , Yasuara K , Maseki T et al. The effects of using a leucocyte removal filter during cold blood cardioplegia . Jpn J Surg 1994; 24: 966-972 .

30.

Sawa Y , Matsuda H , Shimazaki Y et al. Evaluation of leucocyte-depleted terminal blood cardioplegic solution in patients undergoing elective and emergency coronary artery bypass grafting . J Thorac Cardiovasc Surg 1994; 108: 1125-1131 .

31.

Sawa Y , Taniguchi K , Kadoba K et al. Leucocyte depletion attenuates reperfusion injury in patients with left ventricular hypertrophy . Circulation 1996; 93: 10640-10646 .